Morgan Stanley Forecasts Strong Price Appreciation for UnitedHealth Group (NYSE:UNH) Stock

UnitedHealth Group (NYSE:UNH) had its target price hoisted by research analysts at Morgan Stanley from $468.00 to $529.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. Morgan Stanley’s price target indicates a potential upside of 24.06% from the company’s current price.

UNH has been the topic of a number of other reports. Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target on the stock in a research report on Wednesday, April 1st. KeyCorp upped their target price on shares of UnitedHealth Group from $400.00 to $475.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Robert W. Baird raised shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $287.00 to $453.00 in a research note on Thursday. TD Cowen lifted their target price on shares of UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a research note on Tuesday. Finally, Zacks Research raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $447.29.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $426.39 on Friday. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $404.81 and a 200 day moving average price of $342.28. The firm has a market capitalization of $387.23 billion, a PE ratio of 27.44, a price-to-earnings-growth ratio of 1.59 and a beta of 0.62. UnitedHealth Group has a 12-month low of $234.60 and a 12-month high of $461.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company’s revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts anticipate that UnitedHealth Group will post 18.77 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.28% of the stock is owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently added to or reduced their stakes in the company. Walker Asset Management LLC acquired a new stake in UnitedHealth Group in the second quarter worth about $229,000. Ballast Inc. boosted its stake in shares of UnitedHealth Group by 11.4% in the 2nd quarter. Ballast Inc. now owns 17,484 shares of the healthcare conglomerate’s stock valued at $7,267,000 after purchasing an additional 1,791 shares during the last quarter. Regent Peak Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 21.3% during the second quarter. Regent Peak Wealth Advisors LLC now owns 1,620 shares of the healthcare conglomerate’s stock worth $673,000 after buying an additional 285 shares during the last quarter. Annex Advisory Services LLC lifted its holdings in UnitedHealth Group by 159.6% in the second quarter. Annex Advisory Services LLC now owns 68,577 shares of the healthcare conglomerate’s stock valued at $28,503,000 after buying an additional 42,157 shares during the period. Finally, Whitener Capital Management Inc. grew its holdings in UnitedHealth Group by 43.0% during the 2nd quarter. Whitener Capital Management Inc. now owns 3,893 shares of the healthcare conglomerate’s stock worth $1,618,000 after acquiring an additional 1,171 shares during the period. Institutional investors own 87.86% of the company’s stock.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth beat Q2 estimates on earnings and revenue, driven by improved margins and lower medical costs, and raised its 2026 profit outlook. UnitedHealth shares surge on strong earnings beat and guidance
• Positive Sentiment: Morgan Stanley, Oppenheimer, UBS, RBC, and other firms lifted price targets after the results, signaling stronger Street confidence in the stock’s recovery. Analyst price target updates
• Positive Sentiment: Management doubled the 2026 share repurchase target to at least $5 billion, which may help support EPS and investor returns. What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’
• Neutral Sentiment: Commentary around the earnings call says Medicare Advantage and Optum are improving, but commercial cost pressures could delay a full margin recovery. UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
• Negative Sentiment: Some analysts remain cautious, with at least one downgrade noting that the turnaround still faces execution risk despite the stronger quarter. UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.